Capital Management, Llcra C... Net Worth

The estimated Net Worth of Capital Management, Llcra C... is at least $61.7 Milhão dollars as of 12 November 2008. Capital C owns over 48,465 units of Biospecifics Technologies stock worth over $61,732,766 and over the last 16 years Capital sold BSTC stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Capital C BSTC stock SEC Form 4 insiders trading

Capital has made over 3 trades of the Biospecifics Technologies stock since 2008, according to the Form 4 filled with the SEC. Most recently Capital bought 48,465 units of BSTC stock worth $793,857 on 12 November 2008.

The largest trade Capital's ever made was buying 48,465 units of Biospecifics Technologies stock on 12 November 2008 worth over $793,857. On average, Capital trades about 20,288 units every 4 days since 2008. As of 12 November 2008 Capital still owns at least 697,309 units of Biospecifics Technologies stock.

You can see the complete history of Capital C stock trades at the bottom of the page.

Insiders trading at Biospecifics Technologies

Over the last 33 years, insiders at Biospecifics Technologies have traded over $67,860,045 worth of Biospecifics Technologies stock and bought 7,761,661 units worth $656,708,120 . The most active insiders traders include Capital Management, Llc Kol..., International Plc Endo, eMax Link. On average, Biospecifics Technologies executives and independent directors trade stock every 73 days with the average trade being worth of $6,538,649. The most recent stock trade was executed by International Plc Endo on 2 December 2020, trading 7,344,955 units of BSTC stock currently worth $650,028,518.

What does Biospecifics Technologies do?

Complete history of Capital C stock trades at Biospecifics Technologies

Biospecifics Technologies executives and stock owners

Biospecifics Technologies executives and other stock owners filed with the SEC include:

• Jennifer Chao,
  Independent Chairman of the Board
• Michael Schamroth,
  Independent Director
• Paul Gitman,
  Independent Director
• Mark Wegman,
  Director
• Toby Wegman,
  Director
• Sarah McCabe,
  Stern Investor Relations
• Michael Sherman,
  Independent Director
• Corey Fishman,
  Independent Director
• Alex Monteith,
  Senior Vice President and Chief Business Officer
• Patrick Hutchison,
  Chief Financial Officer
• Joseph Truitt,
  Chief Executive Officer, Director
• Jeffrey Kenneth Vogel,
  
• Jyrki Mattila,
  Director
• Thomas Wegman,
  President
• Of Edwin H. Wegman Estate,
  10% owner
• Patrick M Caldwell,
  Principal Financial Officer
• Partners Lp Bio,
  10% owner
• Albert Horcher,
  
• Lawrence Dobroff,
  CFO
• Max Link,
  Director
• Henry Morgan,
  Director
• George M Gould,
  Director
• Matthew Geller,
  Director
• Capital Management, Llc Kol...,
  
• Capital Management, Llcra C...,
  
• Capital Management, Llcaldr...,
  
• Capital Management, Llc Kol...,
  
• Capital Management, Llcra C...,
  
• J Kevin Buchi,
  Chief Executive Officer
• International Plc Endo,
  10% owner